key takeaway 1: adjuvant therapy optimal duration
Published 4 years ago • 76 plays • Length 6:51Download video MP4
Download video MP3
Similar videos
-
6:41
key takeaway 2: frontline neoadjuvant chemotherapy
-
13:00
key takeaways from esmo: adjuvant and neoadjuvant therapy for nsclc
-
1:25
dr. venook discusses adjuvant chemotherapy duration in crc
-
24:51
optimal duration of adjuvant therapy in stage i, ii, iii crc speaker: dr. turki al fayea
-
3:19
crc: deciding on duration of adjuvant therapy
-
8:01
anti–pd-1 adjuvant therapy in melanoma
-
5:23
adjuvant therapy for stage ii and iii colon cancer
-
3:51
key takeaway 4: right-sided tumors: anti-angiogenic treatment
-
1:30
dr. shields on optimal adjuvant therapy for crc
-
6:59
her2 bc: selection and management of neoadjuvant therapy
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
1:43
dr. ilson discusses the optimal adjuvant therapy for resectable gastric cancer
-
6:09
key takeaways from esmo: adjuvant hr breast cancer
-
21:50
adjuvant therapy: current practice and emerging strategies
-
2:06
dr. tarhini discusses adjuvant therapy for melanoma
-
4:41
key takeaway 3: determining tumor mutational status
-
5:57
key takeaway 2: initial systemic therapy in hcc
-
4:46
key takeaway 5: dosing of multiple kinase inhibitors
-
13:18
managing adjuvant treatment in colorectal cancer, part ii